|
IPMK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84030568561866E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.31969990491143E-10 |
| Normal-vs-Stage2 |
1.31660000013412E-07 |
| Normal-vs-Stage3 |
1.4852008511923E-11 |
| Normal-vs-Stage4 |
4.86840001645561E-09 |
| Stage1-vs-Stage2 |
6.370600E-01 |
| Stage1-vs-Stage3 |
3.434800E-01 |
| Stage1-vs-Stage4 |
4.023000E-01 |
| Stage2-vs-Stage3 |
8.323200E-01 |
| Stage2-vs-Stage4 |
7.683800E-01 |
| Stage3-vs-Stage4 |
8.943600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63600252736751E-11 |
| Normal-vs-AfricanAmerican |
3.788500E-04 |
| Normal-vs-Asian |
5.31260035963044E-10 |
| Caucasian-vs-AfricanAmerican |
5.944200E-01 |
| Caucasian-vs-Asian |
1.344170E-01 |
| AfricanAmerican-vs-Asian |
1.159000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.53779244683028E-13 |
| Normal-vs-Female |
1.66440194959705E-11 |
| Male-vs-Female |
1.264210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.92909999588531E-08 |
| Normal-vs-Age(41-60Yrs) |
4.50750547997814E-14 |
| Normal-vs-Age(61-80Yrs) |
3.72250008595643E-10 |
| Normal-vs-Age(81-100Yrs) |
4.764100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.011190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.113000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.533600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.172400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.386000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.508400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.889700E-02 |
| Classical-VS-Follicular |
1.118280E-02 |
| Classical-VS-Other |
7.442300E-02 |
| Classical-VS-Normal |
9.35159949477793E-10 |
| Tall-VS-Follicular |
8.310000E-01 |
| Tall-VS-Other |
1.758170E-01 |
| Tall-VS-Normal |
9.14120001915819E-09 |
| Follicular-VS-Other |
2.688600E-01 |
| Follicular-VS-Normal |
2.8572699761753E-12 |
| Other-VS-Normal |
9.95520000000027E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0902390101819E-13 |
| Normal-vs-N1 |
1.4261000003124E-07 |
| N0-vs-N1 |
7.150800E-01 |
|
|
